» Articles » PMID: 22519961

Fibrinogen Levels During Trauma Hemorrhage, Response to Replacement Therapy, and Association with Patient Outcomes

Overview
Publisher Elsevier
Specialty Hematology
Date 2012 Apr 24
PMID 22519961
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Low fibrinogen levels are known to occur in trauma. However, the extent of fibrinogen depletion during trauma hemorrhage, the response to replacement therapy and association with patient outcomes remain unclear.

Objectives: The study aims were to: characterize admission fibrinogen level and correlate it with factors associated with injury; describe the time course of fibrinogen depletion and response to replacement therapy; determine the correlation of fibrinogen level with rotational thromboelastography (ROTEM) parameters; evaluate the effect of fibrinogen supplementation ex vivo; and establish the association between fibrinogen level and clinical outcomes.

Methods: This was a prospective cohort study of 517 patients. Blood samples were drawn on admission and after admistration of every 4 units of packed red blood cells. Fibrinogen levels were determined with the Clauss method, and global hemostatic competence was assessed with thromboelastometry. The effect of fibrinogen supplementation was assessed in a subgroup of coagulopathic patients.

Results: Low admission fibrinogen level was independently associated with injury severity score (P < 0.01), shock (P < 0.001), and prehospital fluid volume (P < 0.001). Fibrinogen supplementation during transfusion maintained but did not augment fibrinogen levels. Administration of cryoprecipitate was associated with improved survival. ROTEM parameters correlated with fibrinogen level, and ex vivo fibrinogen administration reversed coagulopathic ROTEM parameters. Fibrinogen level was an independent predictor of mortality at 24 h and 28 days (P < 0.001).

Conclusions: Fibrinogen level is decreased in injured patients on admission and is associated with poor outcomes. ROTEM is a rapid means of assessing hypofibrinogenemia. Earlier administration of specific fibrinogen replacement may improve outcomes, and prospective controlled trials are urgently needed.

Citing Articles

[Diagnostics and management of perioperative bleeding disorders].

Schneider S, Pilch J, Graf M, Schulze-Berge J, Kleinschmidt S Anaesthesiologie. 2025; .

PMID: 40072526 DOI: 10.1007/s00101-025-01518-5.


Resonant acoustic rheometry for assessing plasma coagulation in bleeding patients.

Li W, Bunch C, Zackariya S, Patel S, Buckner H, Condon S Sci Rep. 2025; 15(1):5124.

PMID: 39934385 PMC: 11814410. DOI: 10.1038/s41598-025-89737-z.


Effect of early administration of fibrinogen replacement therapy in traumatic haemorrhage: a systematic review and meta-analysis of randomised controlled trials with narrative synthesis of observational studies.

Burt T, Guilliam A, Cole E, Davenport R Crit Care. 2025; 29(1):49.

PMID: 39875966 PMC: 11773828. DOI: 10.1186/s13054-025-05269-y.


Association of Anaesthetists guidelines: the use of blood components and their alternatives.

Shah A, Klein A, Agarwal S, Lindley A, Ahmed A, Dowling K Anaesthesia. 2025; 80(4):425-447.

PMID: 39781579 PMC: 11885198. DOI: 10.1111/anae.16542.


Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.

Curry N, Davenport R, Thomas H, Fox E, Lucas J, Evans A Health Technol Assess. 2024; 28(76):1-69.

PMID: 39545850 PMC: 11590119. DOI: 10.3310/JYTR6938.